ClinicalTrials.gg
Not yet recruitingNCT07946822Updated Nov 18, 2026

Reducing Alcohol-Involved Suicidal Ideation and Behavior

An interventional study of Skills training and Text messaging in Heavy Episodic Drinking and Suicidal Ideation and Behavior, sponsored by Georgia State University. Not yet recruiting at 1 site in United States. Open to participants aged 21 Years to 54 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Georgia State University · Not applicable, Interventional, and Prevention

How we know

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
21 Years to 54 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 350 studies in Suicidal Ideation with a site in United States — 110 open to participants now, 123 under way, 4 of them phase 3. Suicidal Ideation · United States.

Planned enrollment
56th of 321
240 · median 66
Started
2027
with 6 others
No phase
255 of 350
94 open now
Primary completion
2031-06
later than 118 of 122 live
Registered
349th of 350
by date

Among the 350 studies in Suicidal Ideation with a site in United States, this one is the 56th largest by planned enrollment of the 321 interventional ones that give a count, is one of 7 that started in 2027, is one of 255 with no phase, reaches primary completion later than 118 of the 122 other live ones, and was the 349th registered.

Suicidal Ideation

570 studies on the registry are indexed under Suicidal Ideation; 204 are open to participants now.

Browse Suicidal Ideation studies →

Open to participants now

110 of the 350 studies in Suicidal Ideation with a site in United States are open now. Recruiting first, the newest first:

105 more — sign in →

All 110 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 135 Suicidal Ideation studies recruiting now, 52 (39%) set no upper age limit and 79 (59%) stop at 75 or younger; 54 take children under 18; 32 take healthy volunteers.

This study: 21 Years to 54 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 350 studies in Suicidal Ideation with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn whether a brief skills training can help people cope better with distress and reduce suicidal thoughts and behaviors that happen along with alcohol use. The study looks at this both in a lab and in everyday life. It is for adults ages 21 to 54 who currently have thoughts of suicide and who engage in heavy episodic drinking (drinking a large amount of alcohol on a single occasion; specifically, 4 drinks in 2 hours for females and 5 drinks in 2 hours for males).

The main questions it aims to answer are:

  • Can two coping skills from Dialectical Behavior Therapy (paced breathing and expanding awareness) reduce distress, suicidal thoughts, and urges to self-harm while a person has been drinking alcohol?
  • Can text messages sent during the two weeks after the lab visit help people who drink alcohol have fewer suicidal thoughts and behaviors, compared with getting no text messages?
Read the detailed description

Suicide is a serious public health problem in the United States, accounting for more than 47,000 deaths in 2019. Rates of suicide have increased 33% in the past 20 years and have consistently ranked within the 10 leading causes of death in the United States. Decades of rigorous research has consistently found that alcohol is associated with suicidal ideation and behavior (SIB). Despite interventions shown to reduce SIB while sober, high rates of intoxicated SIB may persist because current skills-based interventions: (1) are time and resource intensive, (2) may not be salient to individuals while drinking limiting their ability to engage in them to decrease distress and (3) may be too complicated to use effectively when intoxicated even if they are salient.

Distress tolerance skills from Dialectical Behavior Therapy (DBT) have been shown to be acceptable and effective for suicidal individuals who engage in heavy episodic drinking (HED). However, it is unknown if these skills are effective while intoxicated when risk for SIB is known. Moreover, just-in-time (JIT) interventions may be critical for reducing alcohol-involved SIB because they are designed to provide support when needed and can be delivered close in time to drinking episodes when in-the-moment distress and SIB risk.

The investigators carefully selected two DBT skills simple enough to be implemented while intoxicated to prevent intoxicated SIB. These two skills use counts of 5 and 7 to focus attention on internal and environmental stimuli (expanding awareness skill) and counting breaths (paced breathing skill), hereafter referred to as "5-7 skills". Expanded awareness is a mindfulness skill that can mitigate the myopic narrowing of attentional focus on suicidal thoughts during intoxication. Paced breathing is a distress tolerance skill that can reduce in-the-moment distress by activating the parasympathetic nervous system within minutes. The 5-7 skills are ideal for reducing intoxicated SIB due to their simplicity thus increasing their usability and feasibility while intoxicated.

This study will conduct a proximal change experiment and a micro-randomized trial (MRT) of a brief mobile-based behavioral intervention for SIB while intoxicated. Specifically, the investigators will evaluate the efficacy of 5-7 skills under conditions of acute intoxication using a laboratory-based proximal change experiment to evaluate the efficacy of skills in a controlled environment. Next, the investigators will conduct an MRT to evaluate and optimize the delivery of a JIT intervention including 5-7 skills.

Upon arrival to the laboratory, participants will undergo a brief survey to re-ensure eligibility and to assess biological eligibility. Participants will also complete a field sobriety test. Next, participants will complete the pre-session suicide risk assessment (UWRAMP) to assess for baseline suicide risk upon entering the study. Participants will complete a baseline survey and will then be randomized to the intervention or control condition.

All participants will be served alcoholic (alcohol/juice) drinks. Participants will be administered two drinks consisting of an overall dose to reach .08% breath alcohol concentration (i.e., .816 ml/lb of 100 proof alcohol for males, .752ml/lb of 100 proof alcohol for females) mixed in a 1:3 ratio with juice. The beverage will be poured into two glasses in equal quantities. Participants will be given each drink at equally-spaced times during a twenty-minute interval to control for drinking rate. BrACs will be monitored every five minutes after finishing their beverages with the Alco-Sensor IV breath analyzer. Subjective intoxication and suicidal urges will be assessed each time they are breathalyzed. Once participants reach a criterion BrAC of .05% or greater they will complete the distress tolerance tasks.

Participants will complete two tasks which assess distress tolerance including a mirror tracing task and the PASAT (Paced Auditory Serial Addition Test; see questionnaire battery for a description of each assessment). Participants will either be instructed to practice the 5-7 skills while completing the assessments of distress tolerance if they were assigned to the 5-7 condition or provided no instructions for the control condition. Suicidal and self-harm urges, distress, and alcohol cravings will be assessed during the distress tolerance assessments. Participants' BrAC will be assessed following the completion of these tasks to ensure participants were on the ascending BrAC limb during the experimental procedures. Participants will be served lunch. BrAC will continue to be assessed every 20 minutes. Suicidal/self-harm urges will continue to be assessed verbally via an experimenter while participants are on the descending BrAC limb. Participants will not be allowed to leave the laboratory until their BrAC has fallen to 0.02% on two consecutive readings (following NIAAA guidelines) and they have passed a field sobriety test, and in accordance with prior procedures used by the research team. The post-session suicide risk assessment will be completed prior to completing study procedures to ensure participant safety. Upon completion of study tasks, study personnel will arrange a safe departure for the participant (e.g., Uber/Lyft, bus/train pass, friend/family member pick up).

Following the in-lab session, participants will be asked to complete twice-daily surveys each morning and evening for 14 days to assess their affect, distress, SIB, and alcohol use. Following each report or at the end of the response window if no report is made, the delivery of JIT text messages will be micro-randomized, once in the morning following the morning report, and once in the evening following the evening report. Participants will be randomized with equal probability to receive (a) a message focusing on a 5-7 skill or (b) no message. Participants will receive on average 1 message per day (either in the morning or the evening), with equal chance of receiving each of the 5-7 skills (expanded awareness or paced breathing). Messages will be sent automatically using Qualtrics, which allows users to set-up SMS message triggers following a survey completion or at a predetermined time if no survey was completed.

03

Conditions studied

  • Heavy Episodic Drinking
  • Suicidal Ideation and Behavior
04

Who can participate

Ages eligible
21 Years to 54 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ages 21 to 54
  • Suicidal ideation at least once in the past month;
  • Heavy episodic drinking at least once in the past month

Exclusion criteria

Exclusion Criteria:

  • Any medical to alcohol use
  • Past-month opioid use
  • Pregnant
  • Have had a psychotic episode in the past month
  • Are in or seeking treatment for an alcohol use disorder
  • Have not consumed the amount of alcohol in the past month that would be administered during the proximal change experiment
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
240 participants (estimated)

Study arms

  • Experimental
    5-7 Skills Training

    Skills training followed by randomized text messages.

    Behavioral: Skills training · Behavioral: Text messaging

  • Other
    Assessment-Only Control

    Assessment-only in the lab, with no skills training, followed by the same randomized text messages. This group is first introduced to the skills through the messages.

    Behavioral: Text messaging

Interventions

  • BehavioralSkills training

    The skills training session lasts for 30 minutes, where a researcher teaches two existing evidence-based skills from Dialectical Behavior Therapy to the participant and provides time to practice with feedback and reflection. Expanded Awareness skill: Participants observe five internal experiences (e.g., physical sensations, thoughts, emotions), then participants observe seven things in their environment (e.g., sounds, objects, colors). This intentional expansion of attention is intended to counter cognitive effects of intoxication that may restrict attention to distress/suicidal urges for individuals with SIB. Paced breathing skill: Participants are instructed to slow down their breathing so that their exhalation is longer than their inhalation (e.g., 5-second inhalation, 7-second exhalation). This intentional slowing of one's breathing affects the parasympathetic nervous system and helps to slow down other physical sensations associated with physiological arousal (e.g., heart rate).

  • BehavioralText messaging

    Following their lab visit, participants will complete twice-daily surveys each morning and evening for 14 days to assess their affect, distress, SIB, and alcohol use. Following each report or at the end of the response window if no report is made, the delivery of JIT text messages will be micro-randomized, once in the morning following the morning report, and once in the evening following the evening report. Participants will be randomized with equal probability to receive (a) a message focusing on a 5-7 skill or (b) no message. Participants will receive on average 1 message per day (either in the morning or the evening), with equal chance of receiving each of the 5-7 skills (expanded awareness or paced breathing).

06

What researchers measure

Primary outcomes

  1. Suicidal Urges During the Laboratory Session

    Suicidal ideation assessments will include additional questions specifically tailored to this research project to assess suicidal ideation and behavior while intoxicated. Participants will be asked, "On a scale of 1 (no urges at all) to 10 (the strongest, most intense urges possible), rate the intensity of your suicidal urges." Ratings are collected at baseline, every 5 minutes during alcohol administration before the distress tolerance tasks, and every 20 minutes after the tasks are completed.

    Time frame: Day 1 (baseline through end of laboratory session)

  2. Self-Harm Urges During the Laboratory Session

    Suicidal ideation assessments will include additional questions specifically tailored to this research project to assess suicidal ideation and behavior while intoxicated. Participants will be asked, "On a scale of 1 (no urges at all) to 10 (the strongest, most intense urges possible), rate the intensity of your urge to harm yourself." Ratings are collected at baseline, every 5 minutes during alcohol administration before the distress tolerance tasks, and every 20 minutes after the tasks are completed.

    Time frame: Day 1 (baseline through end of laboratory session)

  3. Suicidal Thoughts in Daily Surveys Over 14 Days

    Suicidal thoughts assessed using items adapted from Dialectical Behavior Therapy (DBT) diary cards, including questions about experiences while intoxicated, completed in an online survey each morning and evening for 14 days following the laboratory session. Participants will be asked to consider their most intense thought of the day and answer the following questions on a scale of 1 (no thoughts at all) to 10 (the strongest, most intense thoughts): What was the intensity of your suicidal thoughts \[today/yesterday\]?

    Time frame: Up to 14 days after the laboratory session

  4. Suicidal Urges in Daily Surveys Over 14 Days

    Suicidal urges will be assessed using an item adapted from Dialectical Behavior Therapy (DBT) diary cards, including questions about experiences while intoxicated, completed in an online survey each morning and evening for 14 days following the laboratory session. Participants will be asked to consider their most intense urge of the day and answer the following question on a scale of 1 (no urges) to 10 (the strongest, most intense urges): What was the intensity of your suicidal urges \[today/yesterday\]?

    Time frame: Up to 14 days after the laboratory session

  5. Distress Tolerance During the Laboratory Session as Assessed by a Modified DTS

    Distress tolerance is assessed using a modified version of the Distress Tolerance Scale, adapted to assess distress tolerance while intoxicated. Each item is rated from 0 (strongly disagree) to 5 (strongly agree). Mean scores range from 0 to 5, with higher scores indicating lower distress tolerance (worse outcome).

    Time frame: Day 1 (during distress tolerance tasks)

  6. Distress Tolerance During the Laboratory Session as Assessed by MTPT-C

    The Mirror Tracing Persistence Task Computerized Version (MTPT-C) will be used to assess distress tolerance in the proximal change experiment. For the task, the score is the time in seconds spent on the final, most difficult level (minimum 0; maximum is the task time limit). Shorter times indicate lower distress tolerance (worse outcome); longer times indicate higher distress tolerance (better outcome).

    Time frame: Day 1 (during distress tolerance tasks)

  7. Distress Tolerance During the Laboratory Session as Assessed by PASAT-C

    The Paced Auditory Serial Addition Test-Computerized version (PASAT-C) will be used to assess distress tolerance in the proximal change experiment. For the task, the score is the time in seconds spent on the final, most difficult level (minimum 0; maximum 600). Shorter times indicate lower distress tolerance (worse outcome); longer times indicate higher distress tolerance (better outcome).

    Time frame: Day 1 (during distress tolerance tasks)

  8. Distress Tolerance During the Laboratory Session via Self-Report

    Participants will answer a self-report measure of distress (e.g., "On a scale of 1 (no distress at all) to 100 (the most distress possible), rate your level of distress).

    Time frame: Day 1 (during distress tolerance tasks)

  9. Distress Tolerance in Daily Surveys Over 14 Days

    Two items will be randomly selected from the 15-item Distress Tolerance Scale to be assessed during each EMA survey over 14 days. Distress tolerance is assessed in each daily survey (morning and evening) using items adapted from the Distress Tolerance Scale. Each item is rated from 1 (strongly disagree) to 5 (strongly agree). At each survey, the score is the mean rating of the items administered (range 1 to 5), with higher scores indicating lower distress tolerance (worse outcome).

    Time frame: Up to 14 days after the laboratory session

  10. Suicidal Ideation and Behaviors as Assessed by C-SSRS

    Suicidal ideation and behaviors will be assessed using the Columbia-Suicide Severity Rating Scale (C-SSRS) at baseline and each follow-up assessment.

    Time frame: From baseline to 14 days after the laboratory session

07

Study locations

1 site
08

References and documents

Publications

  • Cherpitel CJ, Borges GL, Wilcox HC. Acute alcohol use and suicidal behavior: a review of the literature. Alcohol Clin Exp Res. 2004 May;28(5 Suppl):18S-28S. doi: 10.1097/01.alc.0000127411.61634.14. PubMed 15166633 ↗
  • Miller IW, Norman WH, Bishop SB, Dow MG. The Modified Scale for Suicidal Ideation: reliability and validity. J Consult Clin Psychol. 1986 Oct;54(5):724-5. doi: 10.1037//0022-006x.54.5.724. No abstract available. PubMed 3771893 ↗
  • Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, Currier GW, Melvin GA, Greenhill L, Shen S, Mann JJ. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011 Dec;168(12):1266-77. doi: 10.1176/appi.ajp.2011.10111704. PubMed 22193671 ↗
  • Ward-Ciesielski EF, Tidik JA, Edwards AJ, Linehan MM. Comparing brief interventions for suicidal individuals not engaged in treatment: A randomized clinical trial. J Affect Disord. 2017 Nov;222:153-161. doi: 10.1016/j.jad.2017.07.011. Epub 2017 Jul 6. PubMed 28709022 ↗
  • Wilks CR, Lungu A, Ang SY, Matsumiya B, Yin Q, Linehan MM. A randomized controlled trial of an Internet delivered dialectical behavior therapy skills training for suicidal and heavy episodic drinkers. J Affect Disord. 2018 May;232:219-228. doi: 10.1016/j.jad.2018.02.053. Epub 2018 Feb 17. PubMed 29499504 ↗
  • Gilmore AK, Moore CJ, Nielsen KE, Prince JR, Fortson K, Nicole Mullican K, Hutchins A, Ellis J, Leone RM, Ward-Ciesielski E. Mixed method examination of alcohol and suicidality among actively suicidal adults who engage in heavy episodic drinking. Addict Behav. 2024 Apr;151:107938. doi: 10.1016/j.addbeh.2023.107938. Epub 2023 Dec 19. PubMed 38217943 ↗

Individual participant data

Plan to share: Yes — A Global Unique Identifier (GUID) will be generated for each participant so that data can be linked without using personal identifiers. De-identified individual participant data will be shared through the NIAAA Data Archive (NIAAADA), which is housed within the NIMH Data Archive (NDA), in accordance with the study's data sharing plan.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2027; primary completion for Jun 2031, 50 months later.

Of 282 non-industry interventional studies with no phase under Suicidal Ideation, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 54. This study's planned 50 months is above that.

Counting every sponsor, half of 291 studies reached it within 30 months; a quarter within 13 and three quarters within 54.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 20, 2026
First posted
Nov 18, 2026
StartEst.
Apr 2027
Primary completionEst.
Jun 2031
CompletionEst.
Jun 2031
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07946822
Lead sponsor
Georgia State University
Responsible party
Amanda Gilmore (Professor, Georgia State University) — Principal investigator
First posted
Nov 18, 2026
Start date
Apr 2027 (estimated)
Primary completion
Jun 2031 (estimated)
Completion
Jun 2031 (estimated)
Last update
Nov 18, 2026

Study contacts

Kennicia Fortson, PhD
Contact
kfortson4@gsu.edu
404-413-1416
Nicole Mullican, PhD
Contact
kmullican@gsu.edu
Amanda K Gilmore, PhD
principal investigator · Georgia State University
Cynthia Stappenbeck, PhD
principal investigator · Georgia State University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion